Sex: U
Vaccine: COVID19, COVID19
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: Excursion began on 30Jan and experienced severa excursions until 14Feb2023; product storage error; Intercepted medication error; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion began on 30Jan and experienced severa excursions until 14Feb2023), PRODUCT STORAGE ERROR (product storage error), INTERCEPTED MEDICATION ERROR (Intercepted medication error) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Feb-2023, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion began on 30Jan and experienced severa excursions until 14Feb2023), PRODUCT STORAGE ERROR (product storage error), INTERCEPTED MEDICATION ERROR (Intercepted medication error) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion began on 30Jan and experienced severa excursions until 14Feb2023), PRODUCT STORAGE ERROR (product storage error), INTERCEPTED MEDICATION ERROR (Intercepted medication error) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion began on 30Jan and experienced severa excursions until 14Feb2023), PRODUCT STORAGE ERROR (product storage error) and INTERCEPTED MEDICATION ERROR (Intercepted medication error).    This will have to be considered to be an invalid case as there was no individual patient information was reported.  Concomitant medications details were not reported by the reporter.  Reportedly, Reporter became aware of a temperature excursion for Moderna vaccine that was stored in the freezer, they looked at temperature excursion tool and this situation was a little bit interesting, so they wanted to speak to someone. Vaccinee said it looks like 3 doses of the primary monovalent were given on 02-Feb-2023 (1 dose) at that time excursion duration was 90 minutes maximum temperature minus 4 degree Celsius and on 06-Feb-2023 (2 doses) at that time excursion duration was 126 minutes max temperature minus 4 degree Celsius. Possible Monovalent lot numbers were provided as 6 month 5 years: AS1417B 14-May-2023, 6 years to 11 years: AR5186C 17-Feb-2023, 018C22A 09-Apr-2023, 12 and up: 047C22A 24-Mar-2023, 060B22A 26-Feb-2023, 074B22A 11-Mar-2023 Maximum temperature 14.1 degree Celsius, duration above minus 15 degrees Celsius : cumulative duration 122 hours and 22 minutes, duration above 8 degrees C: for about a cumulative duration above 18 hours 37 minutes Excursion began on 30-Jan and experienced several excursions until 14-Feb-2023. Vaccines were currently stored in the fridge as of this morning 14-Feb-2023 around 8:30 AM.  Treatment details were not reported by the reporter.    This case was linked to US-MODERNATX, INC.-MOD-2023-710558, US-MODERNATX, INC.-MOD-2023-710839, US-MODERNATX, INC.-MOD-2023-710848 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-710558: case US-MODERNATX, INC.-MOD-2023-710848:Same reporter US-MODERNATX, INC.-MOD-2023-710839: